New Zealand vs United States: Proportion of isolates with resistance to ciprofloxacin reported to
New Zealand
18.02
in 2017
United States
31.22
in 2018
New Zealand rank
52nd
United States rank
50th
Proportion of isolates with resistance to ciprofloxacin reported to over time
- New Zealand
- United States
How they compare
United States currently reports 31.22 against 18.02 in New Zealand, a difference of 13.2.
That makes United States's figure about 1.7 times New Zealand's.
The two have swapped places 1 time across 9 shared years of data; in 2009 it was New Zealand ahead.
New Zealand ranks 52nd and United States ranks 50th of 54 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.04 | 9.63 | 25.42 | New Zealand |
| 2010s | 37.58 | 19.37 | 18.21 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to ciprofloxacin reported to, New Zealand or United States?
- United States, at 31.22 against 18.02 in New Zealand as of 2018.
- What is the difference in proportion of isolates with resistance to ciprofloxacin reported to between New Zealand and United States?
- 13.2, with United States ahead.
- How many years of comparable data are there for New Zealand and United States?
- 9 years are reported by both, from 2009 to 2017.
- How do New Zealand and United States rank globally for proportion of isolates with resistance to ciprofloxacin reported to?
- New Zealand ranks 52nd and United States ranks 50th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.